159 related articles for article (PubMed ID: 34170808)
1. Transition Metal-mediated Uncaging Chemistry in Prodrug Design.
Shu HY; De Zhu R; Wu J; Liu XH; Shi JB
Curr Top Med Chem; 2021; 21(24):2205-2212. PubMed ID: 34170808
[TBL] [Abstract][Full Text] [Related]
2. Prodrug Activation by Gold Artificial Metalloenzyme-Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination.
Chang TC; Vong K; Yamamoto T; Tanaka K
Angew Chem Int Ed Engl; 2021 May; 60(22):12446-12454. PubMed ID: 33719151
[TBL] [Abstract][Full Text] [Related]
3. Transition-metal-mediated uncaging in living human cells—an emerging alternative to photolabile protecting groups.
Völker T; Meggers E
Curr Opin Chem Biol; 2015 Apr; 25():48-54. PubMed ID: 25561021
[TBL] [Abstract][Full Text] [Related]
4. Carbon-supported palladium and ruthenium nanoparticles: application as catalysts in alcohol oxidation, cross-coupling and hydrogenation reactions.
García-Suárez EJ; Lara P; García AB; Philippot K
Recent Pat Nanotechnol; 2013 Nov; 7(3):247-64. PubMed ID: 22946626
[TBL] [Abstract][Full Text] [Related]
5. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
6. Chemical Activation in Blood Serum and Human Cell Culture: Improved Ruthenium Complex for Catalytic Uncaging of Alloc-Protected Amines.
Völker T; Meggers E
Chembiochem; 2017 Jun; 18(12):1083-1086. PubMed ID: 28425643
[TBL] [Abstract][Full Text] [Related]
7. In vivo catalyzed new-to-nature reactions.
Rebelein JG; Ward TR
Curr Opin Biotechnol; 2018 Oct; 53():106-114. PubMed ID: 29306675
[TBL] [Abstract][Full Text] [Related]
8. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
[TBL] [Abstract][Full Text] [Related]
9. Concurrent and orthogonal gold(I) and ruthenium(II) catalysis inside living cells.
Vidal C; Tomás-Gamasa M; Destito P; López F; Mascareñas JL
Nat Commun; 2018 May; 9(1):1913. PubMed ID: 29765051
[TBL] [Abstract][Full Text] [Related]
10. Organogold reactivity with palladium, nickel, and rhodium: transmetalation, cross-coupling, and dual catalysis.
Hirner JJ; Shi Y; Blum SA
Acc Chem Res; 2011 Aug; 44(8):603-13. PubMed ID: 21644576
[TBL] [Abstract][Full Text] [Related]
11. Differential reactivities of enyne substrates in ruthenium- and palladium-catalyzed cycloisomerizations.
Trost BM; Gutierrez AC; Ferreira EM
J Am Chem Soc; 2010 Jul; 132(26):9206-18. PubMed ID: 20545356
[TBL] [Abstract][Full Text] [Related]
12. Simple and selective sensing of cysteine using gold nanoparticles modified by ruthenium(II) complexes.
Li MJ; Zhan CQ; Zheng YM; Chen GN; Chen X
J Nanosci Nanotechnol; 2011 Apr; 11(4):3578-85. PubMed ID: 21776739
[TBL] [Abstract][Full Text] [Related]
13. Bioorthogonal release of anticancer drugs
Vong K; Yamamoto T; Chang TC; Tanaka K
Chem Sci; 2020 Sep; 11(40):10928-10933. PubMed ID: 34094342
[TBL] [Abstract][Full Text] [Related]
14. Noble metal-dithiocarbamates precious allies in the fight against cancer.
Nagy EM; Ronconi L; Nardon C; Fregona D
Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
[TBL] [Abstract][Full Text] [Related]
15. Expanding Transition Metal-Mediated Bioorthogonal Decaging to Include C-C Bond Cleavage Reactions.
Dal Forno GM; Latocheski E; Beatriz Machado A; Becher J; Dunsmore L; St John AL; Oliveira BL; Navo CD; Jiménez-Osés G; Fior R; Domingos JB; Bernardes GJL
J Am Chem Soc; 2023 May; 145(19):10790-10799. PubMed ID: 37133984
[TBL] [Abstract][Full Text] [Related]
16. Pentannulation of Heterocycles by Virtue of Precious Metal Catalysis.
Petrović M; Occhiato EG
Chem Asian J; 2016 Mar; 11(5):642-59. PubMed ID: 26551353
[TBL] [Abstract][Full Text] [Related]
17. Streptavidin reduces oxygen quenching of biotinylated ruthenium(II) and palladium(II) complexes.
Soller T; Ringler M; Wunderlich M; Klar TA; Feldmann J; Josel HP; Koci J; Markert Y; Nichtl A; Kürzinger K
J Phys Chem B; 2008 Oct; 112(40):12824-6. PubMed ID: 18783263
[TBL] [Abstract][Full Text] [Related]
18. Multi-component syntheses of heterocycles by transition-metal catalysis.
D'Souza DM; Müller TJ
Chem Soc Rev; 2007 Jul; 36(7):1095-108. PubMed ID: 17576477
[TBL] [Abstract][Full Text] [Related]
19. Nano-palladium is a cellular catalyst for in vivo chemistry.
Miller MA; Askevold B; Mikula H; Kohler RH; Pirovich D; Weissleder R
Nat Commun; 2017 Jul; 8():15906. PubMed ID: 28699627
[TBL] [Abstract][Full Text] [Related]
20. In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts.
Clavadetscher J; Indrigo E; Chankeshwara SV; Lilienkampf A; Bradley M
Angew Chem Int Ed Engl; 2017 Jun; 56(24):6864-6868. PubMed ID: 28485835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
